A postdoctoral fellow at the University of Helsinki in Finland, has shed new light on obesity and weight loss mechanisms through her multidisciplinary research on tissue-specific insulin resistance phenotypes and mitochondrial metabolism in adipose tissue and skeletal muscle. Her goal is to advance the development of science-based treatments for obesity by identifying molecular pathways that affect whole-body physiology in successful weight loss and in obesity in an aging population.
The Novo Nordisk Foundation has provided support to the European Association for the Study of Obesity (EASO) for Early Career Network development activities. The Novo Nordisk Foundation has had no influence over award selection or meeting agendas.